Risk factors for atherosclerotic cardiovascular disease (ASCVD) in healthcare professionals of Azar Cohort Study: A cross-sectional Study

Neda Roshanravan ^1,2 , Helda Tutunchi ³, Rezayat Parvizi ², Sepideh Bastani ⁴, Mohammad Asghari Jafarabadi ^5,6,7,8, Elnaz Faramarzi ⁹, Naimeh Mesri Alamdari ³ , Zohreh Ghoreishy ¹⁰, Faezeh Tarighat ¹¹, Kazem Mehravani ², Milad Vahedinezhad ¹², Nazli Namazi ¹³ * , Samad Ghaffari ² *

Cited by CrossRef: 0

1- Naderi N, fardesharifi M, Allahverdi D, Poustchi H, Yari Z. Independent and Combined Association of Overweight and Obesity and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) with 10-Year Atherosclerotic Cardiovascular Disease Risk in Patients with Type 2 Diabetes. Iranian J Nutr Sci Food Technol. 2026;21(1):23 [Crossref]

2- Ruhela N, Singla A, Trivedi Y, Ahmed M, Chikatimalla R, Gupta S, Jain R. Advancements in lipid-lowering therapy: the role of proprotein convertase subtilisin/kexin type 9 inhibitors and beyond in cardiovascular risk reduction. 2025;36(8):696 [Crossref]